Figure 5From: Distinct serum metabolomics profiles associated with malignant progression in the KrasG12Dmouse model of pancreatic ductal adenocarcinomaPrediction analysis based on test and validation sets. No significant predictability was observed for the stage of early lesions (3-5 months of age), whereas statistical significance was observed at the late stage (13-16 months), likely due to expression of more dominant metabolites at the later stage.Back to article page